Because higher antibody levels may mask the detection of circulating antigen, the combination of circulating CA125 levels with anti-CA125 antibodies has been shown to be more effective than CA125 alone in detecting early epithelial ovarian cancer (EOC) [22]. The gene discussed is MUC16; the disease is ovarian carcinoma.